You are here

Event

International Conference on Family Planning: #NextGenFP and FHI 360

November 07, 2018

Portrait of man, woman and babyFHI 360 will join the global health community at the International Conference on Family Planning (ICFP) November 12-15, 2018, in Kigali, Rwanda. FHI 360’s technical presence at the conference will show how our experts, research and programs are shaping the next generation of family planning.

We hope you will join the conversation and share your ideas for #NextGenFP. FHI 360 will have a robust digital engagement platform, so please follow @fhi360 on Twitter and Facebook.

FOLLOW THE CONFERENCE ON THE DIGITAL HUB

If you are not able to attend the conference in person, check out the official virtual conference hub. FHI 360 is a proud media partner assisting with the hub. Also be sure to visit the #ICFP2018 Virtual Conference on Facebook.

FACEBOOK LIVE

FHI 360 will convene several Facebook Live interviews at ICFP. Follow FHI 360 on Facebook for updates. Have a question for a speaker? Include the #NextGenFP hashtag.

HIGHLIGHTS OF OUR TECHNICAL PRESENCE

View the full list of presentations and events from FHI 360. Highlights are below.


Preconference

Do social norms matter for adolescents and family planning? Launch of the Journal of Adolescent Health special supplement Space limited; registration required
November 11 5:00PM-7:00PM


Satellite session

Community-based access to injectable contraception: New tools and research from FHI 360 Space limited; registration required
November 12 10:00AM-1:00PM


Youth lounge event

Advocacy toolkit knowledge café: Utilizing the Global Consensus statement to expand the method mix for youth
November 14 10:00AM-10:30AM


Oral presentation

A deep dive into side effects and their role in method continuation: A longitudinal study of LARC users in Senegal
November 14 10:25AM-11:45AM


Oral presentation

Impact of removing injectables from the contraceptive method mix: An interactive model
November 14 4:20PM-5:40PM


Oral presentation

Research to practice: Results from a one-year randomized controlled trial of self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) versus provider-administered injection in Malawi and use of research for national rollout
November 15 10:25AM-11:45AM


For more information about FHI 360’s innovative work in family planning, read our overview.


Photo credit: Mbuto Machili/FHI 360